BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 26412065)

  • 1. Brain Structural Effects of Antidepressant Treatment in Major Depression.
    Dusi N; Barlati S; Vita A; Brambilla P
    Curr Neuropharmacol; 2015; 13(4):458-65. PubMed ID: 26412065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Functional Effects of Psychopharmacological Treatment in Major Depression: a Focus on Neural Circuitry of Affective Processing.
    Wessa M; Lois G
    Curr Neuropharmacol; 2015; 13(4):466-79. PubMed ID: 26412066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant short-term and long-term brain effects during self-referential processing in major depression.
    Delaveau P; Jabourian M; Lemogne C; Allaïli N; Choucha W; Girault N; Lehericy S; Laredo J; Fossati P
    Psychiatry Res Neuroimaging; 2016 Jan; 247():17-24. PubMed ID: 26655583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain activation predicts treatment improvement in patients with major depressive disorder.
    Samson AC; Meisenzahl E; Scheuerecker J; Rose E; Schoepf V; Wiesmann M; Frodl T
    J Psychiatr Res; 2011 Sep; 45(9):1214-22. PubMed ID: 21477817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain effects of antidepressants in major depression: a meta-analysis of emotional processing studies.
    Delaveau P; Jabourian M; Lemogne C; Guionnet S; Bergouignan L; Fossati P
    J Affect Disord; 2011 Apr; 130(1-2):66-74. PubMed ID: 21030092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does a single session of electroconvulsive therapy alter the neural response to emotional faces in depression? A randomised sham-controlled functional magnetic resonance imaging study.
    Miskowiak KW; Kessing LV; Ott CV; Macoveanu J; Harmer CJ; Jørgensen A; Revsbech R; Jensen HM; Paulson OB; Siebner HR; Jørgensen MB
    J Psychopharmacol; 2017 Sep; 31(9):1215-1224. PubMed ID: 28351201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anatomical and functional correlates in major depressive disorder: the contribution of neuroimaging studies.
    Rigucci S; Serafini G; Pompili M; Kotzalidis GD; Tatarelli R
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):165-80. PubMed ID: 19670087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.
    Miskowiak KW; Favaron E; Hafizi S; Inkster B; Goodwin GM; Cowen PJ; Harmer CJ
    Psychopharmacology (Berl); 2009 Nov; 207(1):133-42. PubMed ID: 19705104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased α2- and β1-adrenoceptor densities in postmortem brain of subjects with depression: differential effect of antidepressant treatment.
    Rivero G; Gabilondo AM; García-Sevilla JA; La Harpe R; Callado LF; Meana JJ
    J Affect Disord; 2014; 167():343-50. PubMed ID: 25020269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depression.
    Fales CL; Barch DM; Rundle MM; Mintun MA; Mathews J; Snyder AZ; Sheline YI
    J Affect Disord; 2009 Jan; 112(1-3):206-11. PubMed ID: 18559283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study.
    Robertson B; Wang L; Diaz MT; Aiello M; Gersing K; Beyer J; Mukundan S; McCarthy G; Doraiswamy PM
    J Clin Psychiatry; 2007 Feb; 68(2):261-7. PubMed ID: 17335325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine normalizes brain activity during emotionally valenced attentional processing in depression.
    Reed JL; Nugent AC; Furey ML; Szczepanik JE; Evans JW; Zarate CA
    Neuroimage Clin; 2018; 20():92-101. PubMed ID: 30094160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural brain changes as biomarkers and outcome predictors in patients with late-life depression: a cross-sectional and prospective study.
    Ribeiz SR; Duran F; Oliveira MC; Bezerra D; Castro CC; Steffens DC; Busatto Filho G; Bottino CM
    PLoS One; 2013; 8(11):e80049. PubMed ID: 24244606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medial prefrontal cortex activity during memory encoding of pictures and its relation to symptomatic improvement after citalopram treatment in patients with major depression.
    Roy M; Harvey PO; Berlim MT; Mamdani F; Beaulieu MM; Turecki G; Lepage M
    J Psychiatry Neurosci; 2010 May; 35(3):152-62. PubMed ID: 20420766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial.
    Grieve SM; Korgaonkar MS; Etkin A; Harris A; Koslow SH; Wisniewski S; Schatzberg AF; Nemeroff CB; Gordon E; Williams LM
    Trials; 2013 Jul; 14():224. PubMed ID: 23866851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of antidepressants on human brain as detected by imaging studies. Focus on major depression.
    Bellani M; Dusi N; Yeh PH; Soares JC; Brambilla P
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1544-52. PubMed ID: 21138750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of the medial and lateral orbitofrontal cortex in major depression and its treatment.
    Zhang B; Rolls ET; Wang X; Xie C; Cheng W; Feng J
    Mol Psychiatry; 2024 Apr; 29(4):914-928. PubMed ID: 38212376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetoencephalographic Correlates of Emotional Processing in Major Depression Before and After Pharmacological Treatment.
    Domschke K; Zwanzger P; Rehbein MA; Steinberg C; Knoke K; Dobel C; Klinkenberg I; Kugel H; Kersting A; Arolt V; Pantev C; Junghofer M
    Int J Neuropsychopharmacol; 2015 Aug; 19(2):. PubMed ID: 26259960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term escitalopram treatment normalizes aberrant self-referential processing in major depressive disorder.
    Komulainen E; Heikkilä R; Nummenmaa L; Raij TT; Harmer CJ; Isometsä E; Ekelund J
    J Affect Disord; 2018 Aug; 236():222-229. PubMed ID: 29747140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional MRI findings, pharmacological treatment in major depression and clinical response.
    Arnone D
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Apr; 91():28-37. PubMed ID: 30099082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.